期刊文献+

小鼠免疫接种乙型肝炎病毒表面S疫苗引起的细胞毒T淋巴细胞反应 被引量:6

Cytotoxic T Cell Responses to Hepatitis B Virus (HBV) Small Surface Antigen in Mice
暂未订购
导出
摘要 目的 研究小鼠免疫接种乙型肝炎病毒 (HBV)表面 S抗原疫苗 (S- HBs Ag)后引起的特异性、MHC- 限制性细胞毒 T淋巴细胞 (cytotoxic T lymphocytes,CTL)反应。方法 分别给 BAL B/c(H- 2 d)小鼠腹腔内接种 0~ 6 μg S- HBs Ag,2周后加强 1次 ,4周后分离小鼠脾淋巴 T细胞 ,体外用小鼠 Ld限制的、S- HBs Ag特异性 CTL表位多肽 S2 8- 39- 刺激 ;用特异性多肽 S2 8- 39- 、51 Cr标记的 P815细胞作为靶细胞 ;4 h51 Cr释放实验检测 CTL 反应。结果  0、0 .6 5、1.2 5、2 .5、5 μg组小鼠 ,CTL 特异性释放率分别为 31.2 1%± 9.2 3%、4 2 .36 %± 19.32 %、91.2 1%± 2 2 .97%、6 9.2 5 %± 2 4 .13%、5 1.4 9%± 2 1.6 6 1% ;只接受 1次免疫接种的小鼠 ,其脾淋巴细胞特异性 CTL 特异性释放率分别为 2 7.34%± 14 .2 5 %、32 .2 7%± 15 .35 %、5 6 .2 8%± 2 4 .35 %、4 4 .34%± 18.6 5 %、4 0 .76 %±5 6 %。结论  BAL B/c(H- 2 d )小鼠腹腔内接种 S- HBs Ag引起特异性 CTL 反应 ,加强免疫能够提高 CTL 反应。 OBJECTIVE The hepatitis B virus (HBV) small surface vaccine(S HBsAg) specific MHC class Ⅰ restricted cytotoxic T lymphocytes (CTL) responses induced by immunization with S HBsAg in mice were assayed. METHODS BALB/c (H 2 d) mice were injected intraperitoneally (i.p.) with S HBsAg at doses ranging from 0 to 6 μg and boosted after 2 weeks. Four weeks after the last immunization, spleen cells were restimulated in vitro with specific peptides, which represent a L d restricted CTL epitope of the S protein in BALB/c (H 2 d) mice. The specific cytotoxic reactivity of in vivo primed and in vitro restimulated cells was tested against P815 cells impulsed with specific peptides and labeled with 51 Cr. Four hour release assay of 51 Cr was performed. RESULTS The percentages of specific release of the murine spleen lymphocyte in groups 0, 0.65, 1.25, 2.5, 5 μg were 31.21±9.23% , 42.36±19.32%, 91.21±22.97%, 69.25±24.13%, 51.49±21.66%, respectively. For the mice received only priming vaccination, the percentages of specific release of the mice spleen lymphocyte in groups 0, 0.65, 1.25, 2.5, 5 μg were 27.34±14.25%, 32.27±15.35%, 56.28±24.35%, 44.34±18.65% , 40.76±56.00%, respectively. CONCLUSIONS Injection with S HBsAg efficiently primed MHC Ⅰ restricted CTL response to the S HBsAg in BALB/c (H 2 d) mice, which was enhanced by boosting injection.
机构地区 解放军
出处 《中华医院感染学杂志》 CAS CSCD 2003年第7期612-615,共4页 Chinese Journal of Nosocomiology
基金 广东省重点科技项目 (99M0 481 1 G)
关键词 HBV表面S抗原疫苗 BALB/C小鼠 免疫接种 细胞毒T淋巴细胞 S HBsAg BALB/c mice Immunization Cytotoxic T lymphocytes
  • 相关文献

参考文献16

  • 1Wright TL, Lau JYN. Clinical aspects of hepatitis B virus infection[J]. Lancet, 1993, 342: 1340-1344.
  • 2Wong DKH, Cheung AM, O'Rourke K, et al. Effect of al-pha-interferon in patients with hepatitis B e antigen-positive chronic hepatitis B: a meta-analysis [J]. Ann Intern Med,1993, 119: 312-323.
  • 3Lai C, Chien R, Leung N, et al. A one-year trial of lamivudine for chronic hepatitis B[J]. N Engl J Med, 1998, 339: 61-68.
  • 4Dienstag J, Perillo R, Sehiff E, et al. A preliminary trial of lamivudine for chronic hepatitis B infection[J]. N Engl J Med,1995, 333: 1657-1661.
  • 5Pol S, Nalpas B, Driss F, et al. Effieaey and limitations of a specifie immunotherapy in chronic hepatitis B[J]. J Hepatol,2001, 34: 917-921.
  • 6Mancini M, Hadchouel M, Tiollais P, et al. Induction of an-ti-hepatitis B surface antigen (HBsAg). Antibodies in HBsAg producing transgenic mice: a possible way of circumventing "nonresponse" to HBsAg[J]. J Med Virol, 1993, 39: 67-74.
  • 7Akbar SMF, Kurosa K, Tanimoto K, et al. Vaccine therapy for hepatitis B virus (HBV)-carriers: a study in routine HBV-carriers on dose, duration and prognosis [J]. Hepatology,1995, 22: 224A.
  • 8Hervas-Stubbs S, Lasarte J-J, Sarobe P, et al. Therapeutic vaccination of woodchucks against chronic woodchuck hepatitis virus infection[J]. J Hepatol, 1997, 27: 726-737.
  • 9Po S, Driss F, Michel ML, et al. Specific vaccine therapy in chronic hepatitis B infection[J]. Lancet, 1994, 344: 342.
  • 10Wen YM, Wu XH, Hu DC, et al. Hepatitis B vaccine and anti-HBs complex as approach for vaccine therapy [J ].Lancet, 1995, 345: 1575-1576.

同被引文献47

  • 1Feng B, Wei L, Chen M,et al. Dynamic changes of hepatitis B virus polymerase gene including YMDD motif in lamivudinetreated patients with chronic hepatitis B[J]. Microbiological research, 2008,163 (4): 541-8.
  • 2Papatheodoridis GV,Chrysanthos N,Hadziyannis E,etal. Longi- tudinal changes in serum HBV DNA levels and predictors of progression during the natural course of HBeAg-negative chronic hepatitis B virus infection[J]. Journal of viral hepatitis, 2008,15 (6) 593-8.
  • 3Yang PL, Althage A,Chung J,et al. Immune effectors required for hepatitis B virus clearance[J]. Proceedings of the National Academy of Sciences of the United States of America, 2010, 107 (2) ,663-7.
  • 4Schumann A,Fiedler M, Dahmen U, et al. Cellular and humoral immune response to a third generation hepatitis B vaccine[J]. Journal of viral hepatitis,2007,14(8) : 592-598.
  • 5Yang SH,Lee CG,Park SH,et al. Correlation of antiviral Tcell responses with suppression of viral rebound in chronic hepatitis B carriers: a proof-of-concept study[J]. Gene thera- py,2006,13(14) : 1110-1117.
  • 6Chichester JA, Feitelson MA,Calkins CE. Transient inhibition of Thl type cytokine production by CD4 T cells in hepatitis B core antigen immunized mice is mediated by regulatory T cells[J]. Immunology, 2006,118(4) : 438-448.
  • 7Li H,Zhou M, Han J,etal. Generation of murine CTL by a hepatitis B virus specific peptide and evaluation of the adjuvant effect of heat shock protein glycoprotein 96 and its terminal fragments[J]. The Journal of Immunology, 2005,174(1) : 195-204.
  • 8Eishiro Mizukoshi, Marc Ghany, Jay H, et al. Cellular Im-mune Responses to the Hepatitis B Virus polymerase[J]. The Journal of Immunology, 2004,173(9) : 5863-5871.
  • 9Chen W, Zhang Z, Shi M,et al. Activated plasmaeytoid dendritic cells act synergistically with hepatitis B core antigenpulsed monocyte-derived dendritic cells in the induction of hepatitis B virus-specific CD8 T-cell response[J]. Clin Immunoi,2008,129(2) :295-303.
  • 10Mohan N, Gonzalez-Peralta RP, Fujisawa T, et al. Chronic hepatitis C virus infection in children[J]. J Gastmenterol Hepatol, 2010, 50 (2): 123-131.

引证文献6

二级引证文献8

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部